Patrick D Lyden, MD
University of Southern California · Cedars-Sinai Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patrick D Lyden, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:58 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05484154 · Efficacy and Safety Evaluation of 3K3A-APC in Ischemic StrokeZZ Biotech, LLC · withdrawn · Ischemic Stroke · principal investigator
- Ph2NCT02222714 · Safety Evaluation of 3K3A-APC in Ischemic StrokeZZ Biotech, LLC · completed · Ischemic Stroke · principal investigator
- Ph1NCT01660230 · Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult VolunteersZZ Biotech, LLC · completed · Healthy · principal investigator
- Ph2/Ph3NCT01123161 · The Intravascular Cooling in the Treatment of Stroke 2/3 TrialUniversity of California, San Diego · terminated · Stroke, Acute · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)UG3NS119199 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Patrick D Lyden · fiscal years 2022Named on NCT05484154
- ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic strokeU01NS088312 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI Patrick D Lyden · fiscal years 2014 to 2017Named on NCT02222714
- Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) DCCU01NS077352 · NINDS · UNIVERSITY OF IOWA · PI CHRISTOPHER S. COFFEY · fiscal years 2011 to 2026Named on NCT02222714
- Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)U01NS077179 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Merit E CUDKOWICZ, Aleksandar Videnovic · fiscal years 2011 to 2026Named on NCT02222714
- Spot Sign for Predicting and Treating ICH Growth (STOP IT)P50NS044148 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Thomas M Hemmen · fiscal years 2003 to 2012Named on NCT01123161
- Data CoreP50NS044227 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MOHAMMAD HOSSEIN RAHBAR · fiscal years 2002 to 2012Named on NCT01123161
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.